Russia’s sovereign National Wealth Fund (NWF) said it had approved the delivery of 25 million doses of its potential vaccine to Egypt via FARCO-PHARMA The Ministry of Health is currently conducting third-phase clinical testing on two COVID-19 vaccines CAIRO: Russian sources claim that their country will deliver 25 million doses of the Sputnik coronavirus (COVID-19) vaccine to Egypt. The Egyptian government has not confirmed the claims. Russia’s sovereign National Wealth Fund (NWF) said it had approved the delivery of 25 million doses of its potential vaccine to Egypt via FARCO-PHARMA, which it described as a “pioneering pharmaceutical company” in Egypt. In a report published in the Lancet medical journal, Russian scientists said that those who were injected with the Sputnik vaccine had developed COVID-19 antibodies without showing any dangerous side effects. Russia licensed the vaccine for domestic use in August, becoming the first country to take such a step. Egypt’s Ministry of Health and Population spokesman Dr. Khaled Megahed said a number of companies in different countries had submitted reports to the ministry to conduct clinical research on COVID-19 vaccines and that some of those companies had expressed a desire to cooperate with Egypt in manufacturing the vaccine. However, he said that none of those requests has been approved and all are pending further reviews. The Ministry of Health is currently conducting third-phase clinical testing on two COVID-19 vaccines in cooperation with the Chinese companies SINOPHARM and Sinovak. So far, 103,198 cases of COVID-19 have been recorded in Egypt, with 96,494 recoveries and 5,930 fatalities. A number of countries have already purchased the Sputnik vaccine, including India, which has signed a deal with the NWF for the delivery of 100 million doses. India has recorded the second-highest number of cases of COVID-19 in the world. Brazil reportedly purchased 50 million doses of the vaccine and will start testing it in October on 10,000 volunteers. Mexico purchased 32 million doses, Uzbekistan 35 million, and Nepal 25 million. Egypt’s Minister of Health Hala Zayed took part in the third phase of a clinical trial two days ago as part of the G42 package and the For Humanity initiative, a cooperative project between the Chinese government and Emirates Healthcare Group, which includes research into potential COVID-19 vaccines as well as cooperation in manufacturing any successful vaccine. Zayed said Egypt is taking part in the third phase of two clinical trials — along with 100 other countries. The For Humanity initiative, in cooperation with the Chinese government, involves trials in four Arab countries: Egypt, the UAE, Bahrain and Jordan.